A Phase 1/2a Study of STM-416 Administered Intraoperatively to Patients Undergoing Transurethral Resection of Bladder Tumor (TURBT) for Recurrent High-Grade Papillary Bladder Cancer
Clinical Trial Grant
Administered By
Urology
Awarded By
Surge Therapeutics
Start Date
May 7, 2024
End Date
May 24, 2029
Administered By
Urology
Awarded By
Surge Therapeutics
Start Date
May 7, 2024
End Date
May 24, 2029